Order Article Reprints

Wang Y, Shen X-J, Su F-W, Xie Y-R, Wang L-X, Zhang N, Wu Y-L, Niu Y, Zhang D-Y, Zi C-T, et al. Novel Perbutyrylated Glucose Derivatives of (–)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking. Molecules. 2021; 26(14):4361. https://doi.org/10.3390/molecules26144361

Wang, Ya, Xiao-Jing Shen, Fa-Wu Su, Yin-Rong Xie, Li-Xia Wang, Ning Zhang, Yi-Long Wu, Yun Niu, Dong-Ying Zhang, Cheng-Ting Zi, and et al. 2021. "Novel Perbutyrylated Glucose Derivatives of (–)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking" Molecules 26, no. 14: 4361. https://doi.org/10.3390/molecules26144361

Wang, Y., Shen, X.-J., Su, F.-W., Xie, Y.-R., Wang, L.-X., Zhang, N., Wu, Y.-L., Niu, Y., Zhang, D.-Y., Zi, C.-T., Wang, X.-J., & Sheng, J. (2021). Novel Perbutyrylated Glucose Derivatives of (–)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking. Molecules, 26(14), 4361. https://doi.org/10.3390/molecules26144361